LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. announced today that it has been named to the annual FierceBiotech “Fierce 15” list, designating it as one of the top biotechnology companies of 2008. The editors of FierceBiotech evaluated hundreds of privately-held firms based on a variety of factors including company vision, strength of technology, and competitive market position. A complete list of ‘Fierce 15’ companies is available in today’s issue of FierceBiotech and on the FierceBiotech Web site at www.fiercebiotech.com.
